Jazz Pharmaceuticals (JAZZ) Operating Expenses (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Operating Expenses of $732.3 million for Q1 2026, down 23.21% year-over-year from $953.7 million in Q1 2025, and down 22.38% quarter-over-quarter from $943.4 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Operating Expenses (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Operating Expenses history runs 17 years deep, the most recent figure standing at $732.3 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 23.21% year-over-year to $732.3 million; the TTM figure through Mar 2026 stood at $4.5 billion (up 28.99% YoY), while the FY2025 annual figure was $4.7 billion, up 40.14% from the prior year.
- Operating Expenses for Q1 2026 stood at $732.3 million, down from $943.4 million in the prior quarter.
- The five-year high for Operating Expenses was $1.7 billion in Q2 2025, with the low at $726.2 million in Q1 2022.
- The 5-year median for Operating Expenses is $847.3 million (2022), against an average of $927.2 million.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses decreased 28.01% in 2023, then surged 110.11% in 2025.
- Jazz Pharmaceuticals' Operating Expenses stood at $1.2 billion in 2022, then fell by 28.01% to $889.4 million in 2023, then climbed by 0.9% to $897.4 million in 2024, then advanced by 5.12% to $943.4 million in 2025, then decreased by 22.38% to $732.3 million in 2026.
- Business Quant data shows JAZZ's Operating Expenses at $732.3 million in Q1 2026, $943.4 million in Q4 2025, and $1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 960.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 960.10 Mn |
| Mar 31, 2026 | 732.30 Mn |
| Dec 31, 2025 | 943.39 Mn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.73 Bn |
| Mar 31, 2025 | 953.70 Mn |
| Dec 31, 2024 | 897.40 Mn |
| Sep 30, 2024 | 794.76 Mn |
| Jun 30, 2024 | 824.38 Mn |
| Mar 31, 2024 | 835.78 Mn |
| Dec 31, 2023 | 889.44 Mn |
| Sep 30, 2023 | 799.75 Mn |
| Jun 30, 2023 | 799.68 Mn |
| Mar 31, 2023 | 766.76 Mn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 915.89 Mn |
| Jun 30, 2022 | 847.33 Mn |
| Mar 31, 2022 | 726.17 Mn |
| Dec 31, 2021 | 847.35 Mn |
| Sep 30, 2021 | 809.75 Mn |